Latest Financial Outlook News

Western Gold Resources has signed a binding toll milling agreement with Wiluna Mining Corporation, fast-tracking production at its Gold Duke Project. With full mining approvals and a preferred contractor in place, the company is poised to capitalise on soaring gold prices.

Ventia has landed a major $800 million contract to upgrade 175,000 premises from Fibre to the Node to Fibre to the Premises across Australia, reinforcing its role in the nation’s digital infrastructure.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Perseus Mining outlines a robust five-year gold production plan targeting up to 2.7 million ounces with stable costs and strong cash margins, backed by major projects in Africa.

Torque Metals has completed its acquisition of Aston Minerals through court-approved schemes of arrangement, leading to Aston's delisting from the ASX and a reshaped leadership team for the combined entity.

Meeka Metals reports significant new shallow high-grade oxide gold drill results at Turnberry Central, extending the Stage 1 open pit and promising to boost production beyond initial plans.

DGL Group projects a challenging FY25 with profits down sharply despite steady revenue, as it undertakes major cost realignment and operational integration to set the stage for future growth.

Evolution Energy Minerals (EV1) addresses ASX queries over recent share price and volume spikes, attributing the activity to a subsidiary’s new US$2 million term sheet while confirming no undisclosed information.

Maas Group Holdings has reaffirmed its FY25 underlying EBITDA guidance between $215 million and $245 million, while expanding its Melbourne construction materials hub through key acquisitions in asphalt paving and recycling.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Treasury Wine Estates faces a pivotal shift as RNDC ends its California distribution, prompting a strategic rethink amid a slightly lowered FY25 EBIT forecast.